ACXP Acurx Pharmaceuticals
- 2.020
- +0.080+4.12%
Acurx Pharmaceuticals News
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
STATEN ISLAND, N.Y., May 2, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotic
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Alcoa Corporation (NYSE:AA) rose sharply in today's pre-market trading after the company reported better-than-expected sales for its first quarter. The company reported quarterly losses of
Acurx Pharmaceuticals Withdraws Filing for Stock Offering
Acurx Pharmaceuticals Withdraws Filing for Stock Offering
Top Premarket Gainers
HWH International (HWH) shares soared 60% Thursday premarket following a 2% gain in the previous session. Tevogen Bio Holdings (TVGN) shares surged more than 100%, rebounding from Wednesday's losses.
Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV
Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofit
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOntrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN)
Acurx Files Common Stock Offering, No Amount Given
Graphite Bio, SCWorx, Acurx Pharmaceuticals Among Healthcare Movers
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating
H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersOntrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. The company's market cap stands at $14.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN) shares rose 97.46% t
US Futures Trend Lower in Tuesday's Premarket as Investors Await Start of 2-Day Fed Meeting
US stock futures were trending lower in Tuesday's premarket session ahead of the Federal Reserve's two-day policy meeting, which begins later in the day. The Dow Jones Industrial Average futures were
Acurx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Acurx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $12
HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target from $14 to $12.
Acurx Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/19/2024 531.58% HC Wainwright & Co. $14 → $12 Maintains Buy 02/28/2024 636.84% HC Wainwright & Co. → $1
Acurx Pharmaceuticals: Strong Buy on Ibezapolstat's Promising Phase 3 Trials and Strategic Partnerships
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOntrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. The company's market cap stands at $8.4 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 30
Acurx Pharmaceuticals Announces Stock Offering
Acurx Pharmaceuticals Announces Stock Offering
Earnings Call Summary | Acurx Pharmaceuticals(ACXP.US) Q4 2023 Earnings Conference
The following is a summary of the Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript:Financial Performance:Acurx ended the year with cash totaling $7.5 million compared to $9.1 millio
We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully
Analysis
Price Target
No Data
